AOD-9604's mechanism is thought to involve the stimulation of lipolysis and the inhibition of lipogenesis (the formation of new fat), specifically by upregulating the beta-3 adrenergic receptors in adipose tissue
They are also comparable to semaglutide in promoting fat loss, though potential lipo shots side effects such as headaches, nausea, or mild discomfort at the injection site may occur
Much of what is sold online is labeled research only, and the purity of those products is highly variable, with independent testing repeatedly finding under-dosed, degraded, or mislabeled peptides across the unregulated market
Injection-Site and Administration Differences Both peptides are administered subcutaneously in clinical practice, though AOD-9604 was also tested orally
Others lose weight on Ozempic but then hit a plateau or regain weight if they stop the injections
Peptide concentration influences both aggregation and oxidation rates